𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Decision Analysis for Treatment of Clinically Localized Prostate Cancer

✍ Scribed by Michael W. Kattan; Mark E. Cowen; Brian J. Miles

Book ID
107412755
Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
659 KB
Volume
12
Category
Article
ISSN
0884-8734

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prostate cancer laterality as a rational
Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer
✍ Vladimir Mouraviev; Janice M. Mayes; Leon Sun; John F. Madden; Judd W. Moul; Tho πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 120 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Early detection of small‐volume prostate cancer (PCa) has led to the concept of focal therapy to treat PCa as an organ‐sparing, minimally invasive procedure. The authors sought to determine the frequency of unilateral cancers in the contemporary prostate‐specific antigen

Decision analysis using individual patie
Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer
✍ Benjamin D. Sommers; Clair J. Beard; Anthony V. D'Amico; Douglas Dahl; Irving Ka πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 130 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Selecting treatment for clinically localized prostate cancer remains an ongoing challenge. Previous decision analyses focused on a hypothetical patient with average preferences, but preferences differ for clinically similar patients, implying that their optimal therapies

Patient satisfaction with treatment deci
Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study
✍ Richard M. Hoffman; William C. Hunt; Frank D. Gilliland; Robert A. Stephenson; A πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Men with early‐stage prostate carcinoma can choose aggressive treatment or conservative management. The authors used data from a population‐based cohort of men with clinically localized prostate carcinoma to describe satisfaction with treatment decisions 24 months after d